Ilaria Lamberto

Title: Ilaria Lamberto: Pioneering Innovations in Cancer Treatment

Introduction

Ilaria Lamberto, an inventive mind based in Arlington, MA, is making significant strides in the field of oncology with her groundbreaking work on multifunctional molecules. With one patent to her name, she is at the forefront of developing innovative solutions to combat cancer.

Latest Patents

Ilaria Lamberto holds a patent titled "Multifunctional molecules that bind to calreticulin and uses thereof". This invention involves multifunctional molecules that include an antigen binding domain capable of binding to a calreticulin mutant protein. The patent also encompasses various components such as immune cell engagers—NK, T, B, dendritic cell, and macrophage engagers—as well as cytokine molecules and stroma-modifying moieties. Moreover, the patent describes nucleic acids encoding these multifunctional molecules, methods for their production, and therapeutic applications for cancer treatment.

Career Highlights

Ilaria is currently associated with Marengo Therapeutics, Inc., where her innovative research focuses on advancing novel therapeutic strategies for cancer patients. Her work aims to pave the way for more effective and targeted treatments, enhancing the immune response against tumors.

Collaborations

Throughout her career, Ilaria has collaborated with prominent colleagues, including Andreas Loew and John Leonard Herrmann. These collaborations foster a creative and supportive research environment, contributing to the advancement of their shared goals in cancer therapeutics.

Conclusion

Ilaria Lamberto exemplifies the spirit of innovation in the scientific community, specifically within cancer research. Her patent on multifunctional molecules highlights her commitment to developing cutting-edge therapies that have the potential to improve patient outcomes. As she continues her work at Marengo Therapeutics, her contributions could significantly alter the landscape of cancer treatment.